FDA issued a Warning Letter to Kolmar Korea Co. Ltd. on 5/18/2018 as a result of this inspection.
483 Kolmar Korea Sep 2017

483 Kolmar Korea Sep 2017

Pratik Upadhyay FDA$119.00 - Available Now

FDA investigators audited the Kolmar Korea - Sejong-si, Korea (the Republic of) facility and issued inspectional observations (via FDA 483) on 28 Sep 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 28 Sep 2017
  • Location: Sejong-si, Korea (the Republic of)
  • FEI: 3004033751
Add To Cart